MedPath

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

Recruiting
Conditions
Rectal Cancer
Rectosigmoid Cancer
Rectosigmoid Junction Cancer
Interventions
Device: ArtiSential
Registration Number
NCT05566249
Lead Sponsor
Samsung Medical Center
Brief Summary

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Age : 18 ~ 80 year old male or female
  • Biopsy-proven adenocarcinoma
  • Rectal cancer or Rectosigmoid junction cancer
  • Primary cancer
  • Non-metastatic cancer
  • Planned (or elective) curative resection
  • Low anterior resection with double-stapled technique
Exclusion Criteria
  • Preoperative systemic chemotherapy
  • Distant metastasis at initial diagnosis
  • Palliative surgery
  • Emergent surgery
  • Lynch syndrome or FAP-associated cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ArtiSential groupArtiSentialPatients undergoing laparoscopic surgery using ArtiSential
Primary Outcome Measures
NameTimeMethod
Surgical failure1 month

conversion, postoperative complications, or less than 12 harvested lymph nodes

Cost1 month

Total medical cost during hospital stay for surgery

Secondary Outcome Measures
NameTimeMethod
Oncologic outcomes5-year

5-year Overall Survival

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath